Explain this page
Arphra AIPlain-English read on HCA Healthcare, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.12% | -5.07% | -16.13% | -32.96% | -25.38% | -22.20% | -5.18% | +33.43% | +70.32% | +364.85% | +1070.95% |
Aftermarket
LiveLast trade
$366.47
1 sh
Bid
$364.75
1 sh
Ask
$377.00
120 sh
Spread
$12.250
Sector & industry today
LiveSectors
- Healthcare+1.32%
- Financial Services+1.14%
- Industrials+0.68%
- Consumer Cyclical+0.59%
- Energy+0.52%
- Real Estate+0.46%
- Consumer Defensive+0.12%
- Basic Materials-0.28%
- Utilities-1.42%
- Communication Services-1.84%
- Technology-2.36%
Top industries (issuer's industry highlighted)
- Medical - Care Facilities+0.70%
- Rental & Leasing Services+5.32%
- Financial - Mortgages-4.41%
- Broadcasting-4.23%
- Investment - Banking & Investment Services-4.21%
- Software - Application-4.13%
- Auto - Recreational Vehicles+4.13%
- Software - Infrastructure-3.47%
- Information Technology Services-3.40%
- Department Stores+3.03%
- Silver-3.02%
- Apparel - Retail+2.95%
Fair value
Football field →Weighted blend
$1,496.54
+312.01% vs spot
Recommendation
Strong Buy
16 of 18 methods
Method spread
8bull7bear
±5% threshold
Analyst PT consensus: $527.45 (+45.21%)
Total assets
$60.72B
Total debt
$50.2B
Cash & equiv
$1.04B
Operating CF
$12.64B
Free cash flow
$7.69B
Buybacks
-$10.07B
Analyst view
DB · price_targets + analyst_gradesConsensus target
$527.45
+45.21% upside
Low
$436.00
Median
$530.00
High
$635.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $19.11B | $1.62B | $7.15 |
| Q4 Dec 2025 | $19.51B | $1.88B | $8.14 |
| Q3 Sep 2025 | $19.16B | $1.64B | $6.96 |
| Q2 Jun 2025 | $18.61B | $1.65B | $6.83 |
| Q1 Mar 2025 | $18.32B | $1.61B | $6.45 |
| Q4 Dec 2024 | $18.29B | $1.44B | $5.63 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
McAlevey Michael R officer: EVP & Chief Legal & Admin Off. | Sell | 1,694 | $903.54K | Feb 18, 2026 |
Wyatt Christopher F. officer: SVP & Controller | Sell | 4,000 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.11M | Feb 11, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 5,162 | $2.57M | Feb 03, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 14,716 | $7.4M | Feb 03, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $75.6B | $11.97B | $6.78B | $28.38 | +8.97% |
| FY 2024 | $70.6B | $10.55B | $5.76B | $22.00 | +8.16% |
| FY 2023 | $64.97B | $9.63B | $5.24B | $18.96 | +8.07% |
| FY 2022 | $60.23B | $9.05B | $5.64B | $19.15 | +9.37% |
| FY 2021 | $58.75B | $9.68B | $6.96B | $21.16 | +11.84% |